Skip to main content

Naproxen

NDC 76282-342 · Exelan Pharmaceuticals, Inc.

Generic nameNaproxen
Dosage formTABLET
RouteORAL
Active ingredient(s)NAPROXEN
Strength500 mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
Marketing categoryANDA

Packages

76282-342-01 — 100 TABLET in 1 BOTTLE (76282-342-01)

76282-342-05 — 500 TABLET in 1 BOTTLE (76282-342-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71610-597 — Naproxen, 72162-2275 — Naproxen, 72162-2276 — Naproxen, 72189-136 — NAPROXEN, 72189-425 — Naproxen, 72789-003 — Naproxen, 72789-321 — Naproxen, 72789-541 — Naproxen, 76282-340 — Naproxen, 76282-341 — Naproxen, 76420-042 — NAPROXEN, 76420-264 — Naproxen, 76420-787 — Naproxen, 76420-788 — Naproxen, 76420-889 — Naproxen and esomeprazole magnesium, 76420-890 — Naproxen and esomeprazole magnesium, 77771-434 — Naproxen, 77771-435 — Naproxen, 77771-436 — Naproxen, 80425-0010 — Naproxen, +171 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels